Annals of Surgical Oncology

, Volume 15, Issue 1, pp 16–17 | Cite as

Ductal Carcinoma in Situ: Through a Glass, Darkly

Breast Oncology


  1. 1.
    Dawood S, Broglio K, Gonzalez-Angulo AM, et al. Development of new cancers in patients with DCIS: The M.D. Anderson experience. Ann Surg Oncol 2007. doi: 10.1245/s10434-007-9661-8.
  2. 2.
    Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001; 28:400–18PubMedCrossRefGoogle Scholar
  3. 3.
    Meijnen P, Oldenburg H, Peterse J, et al. Clinical outcome after selective treatment for patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 2007. doi: 10.1245/s10434-007-9659-2.
  4. 4.
    Eusebi V, Feudale E, Foschini MP, Micheli A, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11:223–35PubMedGoogle Scholar
  5. 5.
    Bijker N, Peterse JL, Duschateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ. Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19:2263–71PubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  1. 1.The Breast Cancer Consultation ServiceTiburonUSA
  2. 2.Keck School of Medicine, University of Southern CaliforniaLos AngelesUSA

Personalised recommendations